Core Hydrophobicity of Supramolecular Nanoparticles Induces NLRP3 Inflammasome Activation
Overview
Biotechnology
Authors
Affiliations
Designer nanomaterials capable of delivering immunomodulators to specific immune cells have been extensively studied. However, emerging evidence suggests that several of these nanomaterials can nonspecifically activate NLRP3 inflammasomes, an intracellular multiprotein complex controlling various immune cell functions, leading to undesirable effects. To understand what nanoparticle attributes activate inflammasomes, we designed a multiparametric polymer supramolecular nanoparticle system to modulate various surface and core nanoparticle-associated molecular patterns (NAMPs), one at a time. We also investigated several underlying signaling pathways, including lysosomal rupture-cathepsin B maturation and calcium flux-mitochondrial ROS production, to gain mechanistic insights into NAMPs-mediated inflammasome activation. Here, we report that out of the four NAMPs tested, core hydrophobicity strongly activates and positively correlates with the NLRP3 assembly compared to surface charge, core rigidity, and surface hydrophobicity. Moreover, we demonstrate different signaling inclinations and kinetics followed by differential core hydrophobicity patterns with the most hydrophobic ones exhibiting both lysosomal rupture and calcium influx early on. Altogether, this study will help design the next generation of polymeric nanomaterials for specific regulation of inflammasome activation, aiding efficient immunotherapy and vaccine delivery.
Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy.
Surve D, Fish A, Debnath M, Pinjari A, Lorenzana A, Piya S Nat Commun. 2024; 15(1):9035.
PMID: 39426974 PMC: 11490495. DOI: 10.1038/s41467-024-53396-x.
Caspase-1 Responsive Nanoreporter for Monitoring of Inflammasome Immunotherapy.
Nandi D, Forster Iii J, Ramesh A, Nguyen A, Bharadwaj H, Kulkarni A ACS Appl Mater Interfaces. 2023; 15(48):55545-55558.
PMID: 37990965 PMC: 11056827. DOI: 10.1021/acsami.3c15733.
Weiss A, Lopez 2nd M, Rawe B, Manna S, Chen Q, Mulder E Macromolecules. 2023; 56(18):7286-7299.
PMID: 37781211 PMC: 10537447. DOI: 10.1021/acs.macromol.3c01223.
Nanoreporter for Real-Time Monitoring of Inflammasome Activity and Targeted Therapy.
Nandi D, Forster 3rd J, Ramesh A, Nguyen A, Bharadwaj H, Kulkarni A Adv Sci (Weinh). 2023; 10(6):e2204900.
PMID: 36603165 PMC: 9951342. DOI: 10.1002/advs.202204900.
Understanding the immunological interactions of engineered nanomaterials: Role of the bio-corona.
Fadeel B Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(6):e1798.
PMID: 36416023 PMC: 9787869. DOI: 10.1002/wnan.1798.